I have tinnitus, dizziness, palpitations after abusing zolpidem for 5 years,

Potential Causes: In a patient with a history of prolonged zolpidem abuse who is now abstinent for one year, tinnitus, dizziness, and palpitations may arise from several interrelated causes. Chronic zolpidem use, a hypnotic with benzodiazepine-like effects, carries risks of physical and psychological dependence, with withdrawal symptoms potentially persisting or emerging even after cessation due to neurophysiological adaptations. Withdrawal syndrome can include symptoms such as anxiety, restlessness, sensory hypersensitivity, tinnitus, dizziness, and autonomic disturbances like palpitations and tachycardia. These symptoms may represent protracted withdrawal manifestations or benzodiazepine-induced neurological dysfunction, reflecting sustained alterations on GABAergic pathways and receptor sensitivities despite abstinence SmPC Zalzo,SmPC Zalzo,SmPC Zolpidem,SmPC Zolpidem,Brunner et al. 2025.

Other possible causes include concurrent mental health disorders (e.g., anxiety or depression), which are common in patients with substance misuse histories, and may themselves present with palpitations and dizziness. Additionally, tinnitus may be multifactorial: drug-induced ototoxicity during or after zolpidem use, noise exposure, or vascular/neurogenic causes need consideration. The presence of dizziness raises the differential of vestibular disorders, including Meniere's disease or vestibular schwannoma, which may coincide with tinnitus NICE CKS.

Assessment: A thorough clinical history should cover onset, nature, and pattern of tinnitus (unilateral/bilateral, pulsatile/non-pulsatile), and associated symptoms such as hearing loss, vertigo, or neurological signs. Examination includes otoscopy, tuning fork tests, and neurological assessment to exclude alternative pathologies NICE CKS,NICE NG155. Risk factors and history of substance misuse, and previous withdrawal symptoms, should be explored SmPC Zalzo,SmPC Zalzo,Brunner et al. 2025.

Management Strategies: For symptoms likely related to zolpidem withdrawal and protracted neurological effects, management should be patient-specific and multidisciplinary. First, ongoing monitoring of symptoms is essential given that protracted withdrawal can last months to years, with fluctuating severity Brunner et al. 2025. Supportive care includes psychoeducation about the nature of withdrawal and neurological changes, reassurance regarding the typically self-limiting course, and addressing comorbid mental health conditions SmPC Zalzo,SmPC Zalzo,Brunner et al. 2025.

For tinnitus, NICE guidelines recommend audiological assessment, reassurance, and addressing contributory factors such as impacted earwax or ototoxic medication exposure. If tinnitus causes significant distress, management options include sound therapy and cognitive behavioral therapy (CBT), which may also assist in coping with associated insomnia or anxiety NICE CKS,NICE NG155.

Dizziness assessment should exclude serious vestibular or neurological pathology; symptomatic treatment and vestibular rehabilitation may be considered.

Palpitations should prompt cardiovascular evaluation to exclude arrhythmias or other causes, but in withdrawal contexts, autonomic symptoms often improve gradually over time. Careful monitoring during tapering or following cessation of zolpidem is critical to prevent severe withdrawal manifestations including seizures SmPC Zalzo,SmPC Zalzo,Brunner et al. 2025.

When managing patients with histories of zolpidem abuse, clinicians should apply evidence-based tapering protocols if ongoing hypnotic use exists, with slow dose reductions (commonly 5-10% every 2-4 weeks), shared decision-making, and adjunctive psychosocial interventions such as CBT and sleep hygiene techniques to mitigate withdrawal symptoms and reduce risk of relapse Brunner et al. 2025.

For patients already abstinent but with persisting symptoms, referral to specialists in addiction medicine, otolaryngology, or neurology may be indicated for further evaluation and management. Engagement with peer support services and mental health interventions can enhance recovery and coping Brunner et al. 2025.

Summary: In this patient, the tinnitus, dizziness, and palpitations are most likely manifestations of protracted zolpidem withdrawal and associated neurophysiological sequelae, possibly compounded by psychological and vestibular factors. Management involves thorough assessment to exclude other causes, supportive and symptomatic care, psychological therapies, and close monitoring with tailored interventions based on individual patient needs and preferences SmPC Zalzo,SmPC Zalzo,NICE CKS,NICE NG155,Brunner et al. 2025.